Amgen (AMGN) EPS (Diluted) (2009 - 2026)
Amgen (AMGN) recorded EPS (Diluted) of $4.37 in Q2 2026, up 64.9% from $2.65 a year earlier and up 30.6% from the prior quarter.
Powered by 
Analysis
Amgen (AMGN) EPS (Diluted) (2009 - 2026) Analysis & Trends
On a TTM basis, Amgen's EPS (Diluted) came in at $16.07 as of Jun 30, 2026, up 31.4% year-over-year; for FY2025, it was $14.23, up 88.2% from FY2024.
- Annual EPS (Diluted) has a five-year compound annual growth rate of 2.9% (FY2020 to FY2025).
- Across earlier years, EPS (Diluted) came in at $7.56 in FY2024 (-39.4%), $12.49 in FY2023 (+3.1%), $12.11 in FY2022 (+17.8%) and $10.28 in FY2021 (-16.5%).
- Quarterly EPS (Diluted) has ranged from -$0.21 in Q1 2024 to $5.93 in Q3 2025 over the past five years.
- On a year-over-year basis, EPS (Diluted) has increased for five consecutive quarters, with growth averaging 47.3% over the last seven quarters.
- Peak year-over-year performance for EPS (Diluted) in the last five years was growth of 204.5% in Q2 2022, against a decline of 52.3% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.34 (Q1 2026), $2.46 (Q4 2025) and $5.93 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 4.31 |
| 10 | Bristol Myers Squibb | 128.45 Bn | 79.72 Bn | 9.25 Bn | 1.62 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.37 |
| Mar 31, 2026 | 3.34 |
| Dec 31, 2025 | 2.46 |
| Sep 30, 2025 | 5.93 |
| Jun 30, 2025 | 2.65 |
| Mar 31, 2025 | 3.20 |
| Dec 31, 2024 | 1.16 |
| Sep 30, 2024 | 5.22 |
| Jun 30, 2024 | 1.38 |
| Mar 31, 2024 | -0.21 |
| Dec 31, 2023 | 1.43 |
| Sep 30, 2023 | 3.22 |
| Jun 30, 2023 | 2.57 |
| Mar 31, 2023 | 5.28 |
| Dec 31, 2022 | 2.99 |
| Sep 30, 2022 | 3.98 |
| Jun 30, 2022 | 2.45 |
| Mar 31, 2022 | 2.68 |
| Dec 31, 2021 | 3.31 |
| Sep 30, 2021 | 3.31 |
API Access
Amgen EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=AMGN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "AMGN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=AMGN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();